Abstract: Novel approaches in regenerative medicine and tissue engineering are highly promoted by human induced pluripotent stem cells. Typical workflows include the expansion, differentiation and/or cryopreservation of these cells. Often, the differentiation, cytotoxicity tests or disease modelling rely on multicellular aggregates. Here, we present the novel bag-based system "Labbag®" to address workflows required for these applications. As a unique feature, the Labbag® provides a chemical spot pattern to allow the formation of several hundreds of hanging droplets within a few seconds with standard laboratory equipment. In this study, we describe the general concept of the Labbag® and show aggregate formation of stem cells as first stem cell workflow successfully transferred.
Introduction
Since the establishment of protocols for the generation of human induced pluripotent stem cells (hiPSCs) [1] [2] [3] , researchers in this field are able to produce medically relevant, sophisticated artificial micro-tissues for disease modelling [4] (e.g. cardiomyopathy, Alzheimer's disease), drug discovery/testing, and toxicity testing independent from organ donations. Derived from somatic cells, e.g. fibroblasts, patient-specific pluripotent stem cells can be produced [5] and, virtually differentiated into all specialized cell types of the human body [6] . Typical stem cell workflows comprise maintenance, expansion, embryoid body formation, differentiation and cryopreservation. In this field, the generation of three-dimensional aggregates is a fundamental prerequisite [7] either in differentiation protocols [8] or micro-tissue generation [9] . Current techniques for "hanging droplet" cultures [10] are timeconsuming in case of manual pipetting or cost-intensive when pipet robots are used. To circumvent these drawbacks, we studied the feasibility of a defined chemical pattern facilitating the generation of hanging droplets. In addition, a closed bag based cultivation system is advantageous in terms of biotechnological upscaling and GMP regulations, minimizing the risk of (cross-) contaminations but is, so far, not available on the market. In consequence, we have developed in a highly interdisciplinary consortium a disposable, closed, surface-based cultivation system, called "Labbag®". Here, we present the technical concept and characterization of the developed Labbag® system with the successful transfer of stem workflows using hiPSCs. We particularly ______ *Corresponding author: Heiko Zimmermann: Fraunhoferfocus on the generation of three-dimensional aggregates in hanging droplets using a chemical deposited spot pattern.
Materials and methods

Material selection
The used materials for the construction of the Labbags® (Figure 1 a) were carefully evaluated with respect to workflows in human stem cell biology. The existing workflows comprise, roughly, the 2D expansion, 3D aggregation, microscopic observation, differentiation and cryopreservation of hiPSCs. In consequence, the required material for such a challenging system has to provide several properties like sterility, chemical resistance, compatibility to cryogenic temperatures, cytocompatibility, ergonomic handling, high optical quality and transparency, compatibility to laboratory equipment, etc. First, we studied promising material candidates. Overall, a thin polypropylene-based foil emerged as the most suitable candidate with direct contact to the biological material. An additional stabilizing frame made from a thick polypropylene foil was integrated onto the bags surface.
Concept for hanging drop formation
The facilitation of hanging droplet formation without a robotic platform or time-consuming manual pipetting was studied with an approach using a chemical pattern with hydrophobic and hydrophilic features (Figure 1 b) . The patterns were produced by a plasma-assisted coating process optimized for voluminous droplets to create a stable microenvironment for aggregate formation over several days. The hydrophilic spots were deposited using a mask and are, virtually, transferrable to any diameter.
Semi-automatic production
The Labbags® were assembled on a semi-automatic production plant. The central bags were formed in the plant by pre-cuts with spot patterns. A spout for liquid handling is mounted in the bags by heat contact sealing. The stabilizing frame of the Labbags® was fixed by laser-sealing after manual transfer on a second production plant.
Biological workflows
To demonstrate the transfer of biological workflows concerning aggregate formation into the Labbags®, hiPSCs (ER1918) were used. Cells were cultured and expanded in a mTeSR-medium kit (Stemcell Technologies, Grenoble, France). For inoculation, stem cell colonies were dissociated and detached by TrypLE (Gibco, Thermofisher, MA, USA) incubation. Cell density was adjusted to 4e5 cells per mL and supplemented with ROCK inhibitor (Cayman Chemical, Tallinn, Estonia) to suppress apoptosis. A volume of 10 mL was pipetted into each Labbag® and gently swirled over the spot pattern. Droplets were hanged up formed by turning the Labbag® (Figure 1 c, Figure 2 a and b) . The excessive cell suspension was substituted by basal medium DMEM/F-12 (Gibco) in order to humidify the droplet's environment. Manual pipetted droplets (20 µL each) in a bacteriological petri dish were prepared as control. The samples were cultivated for 2 days at 37°C, 5% CO 2 and 95% humidity. Aggregate formation was analysed by manual measurement of the aggregate's equivalent diameter. Viability of aggregates was evaluated by fluorescein diacetate/ethidium bromide staining.
Results and discussion
Handling and biological workflows
We started to transfer relevant stem cell workflows into the Labbag®. In this study, we focused on the fundamental workflow of aggregate formation. The critical evaluation of the Labbag® revealed excellent compatibility to standard laboratory equipment, such as microscopes or serological pipettes. The Labbag® can be processed with one-handed operations similar to standard cell culture flasks. Currently, the sterilization of the Labbags® using ethylene oxide is under investigation or can be realized by UV-irradiation.
Aggregate formation of hiPSC
The successful aggregate formation was assessed by the equivalent diameter (diameter of a circle having the same area as the measured object [11] ) of the aggregates in hanging droplets (Figure 2 c and d ). In the Labbags®, we observed droplets with one central aggregate (Figure 2 d) , but also droplets with more than one central aggregate (Figure 2 c) . Small satellite aggregates are present during the first days and we hypothesize that these merge to one big aggregate over time. In case of flat droplets with low volume, an increased tendency of satellite formation was observed. Aggregates larger than 150 µm (on average) were formed. In two of three Labbags® the diameter of the aggregates was larger than 200 µm with standard deviation of approximately 65 µm. In comparison, manual controls generated aggregates larger than 300 µm with standard deviations smaller than 25 µm (Figure 2 e) . However, the droplets are quite stable and remain at their position if the bag is arranged vertically. The harvest of generated aggregates is conducted by swirling medium over the hanging droplets, turning the bag and collecting the detached aggregates at the bottom of the Labbag®. Aggregates with high viability were further processed (e.g. suspension culture) or analysed (e.g. qPCR analysis).
Conclusion
In this project, we addressed tasks in human stem cell workflows and developed a bag-based demonstrator for standard cultivation, hanging droplet formation and cryopreservation of therapeutically relevant cells. We demonstrated the fast formation of hanging droplets with standard lab equipment on a chemical pattern, leading to the reproducible formation of multicellular hiPSC-aggregates. Hundreds of these mini bioreactors are generated within seconds by swirling the cell suspension over the patterned surface and flipping the bag for subsequent cultivation and aggregate formation. A comparison of existing hanging droplet technologies is given in Table 1 and substantiates the advantages of the Labbag® system. First preliminary results show that cryopreservation (slow rate freezing and vitrification) as well as standard 2D-cultivation should be achievable. The Labbag®-technology provides researchers in stem cell labs and clinical centres a tool for accelerating research related to human stem cells with the possibility to perform all necessary process steps (expansion, differentiation, cryopreservation) in one single cell culture bag. In future, cell-based models produced in Labbags® (not limited to hiPSCs) will contribute to reduce the number of animal tests in the drug discovery pipeline or will create meaningful data for understanding diseases and the development of novel therapies even with the possibility of GMP certification. 
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